We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTEC icon
10101
CALL
TTEC Holdings
TTEC
$69M
$392K ﹤0.01%
3,800
-1,400
-27% -$145K
GMDA
10102
PUT
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$392K ﹤0.01%
61,200
-6,800
-10% -$46.9K
MDH.U
10103
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
$392K ﹤0.01%
39,159
AXGN icon
10104
PUT
Axogen
AXGN
$2.77B
$391K ﹤0.01%
18,100
-1,700
-9% -$34.4K
EUO icon
10105
ProShares UltraShort Euro
EUO
$33.1M
$391K ﹤0.01%
16,396
-3,500
-18% -$80.8K
FCFS icon
10106
FirstCash
FCFS
$9.51B
$391K ﹤0.01%
+5,116
New +$387K
IMUX icon
10107
PUT
Immunic
IMUX
$210M
$391K ﹤0.01%
3,190
-1,530
-32% -$212K
NVVE
10108
PUT
DELISTED
Nuvve Holding Corp
NVVE
0
PLOW icon
10109
PUT
Douglas Dynamics
PLOW
$965M
$391K ﹤0.01%
9,600
+4,200
+78% +$184K
CHAD
10110
DELISTED
Direxion Daily CSI 300 China A Share Bear 1X Shares
CHAD
$391K ﹤0.01%
23,661
-16,333
-41% -$278K
ADAP
10111
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
$390K ﹤0.01%
91,500
-70,200
-43% -$341K
AIZ icon
10112
PUT
Assurant
AIZ
$14.1B
$390K ﹤0.01%
2,500
-600
-19% -$93.7K
MCY icon
10113
PUT
Mercury Insurance
MCY
$5.7B
$390K ﹤0.01%
6,000
-4,700
-44% -$298K
NSIT icon
10114
CALL
Insight Enterprises
NSIT
$4.57B
$390K ﹤0.01%
+3,900
New +$394K
ORIC icon
10115
Oric Pharmaceuticals
ORIC
$1.37B
$390K ﹤0.01%
22,044
-21,312
-49% -$467K
PLYA
10116
PUT
DELISTED
Playa Hotels & Resorts
PLYA
$390K ﹤0.01%
52,500
-14,100
-21% -$104K
GGMCU
10117
DELISTED
Glenfarne Merger Corp. Unit
GGMCU
$390K ﹤0.01%
39,338
+20,138
+105% +$201K
CUE icon
10118
CALL
Cue Biopharma
CUE
$203M
$389K ﹤0.01%
1,113
+700
+169% +$271K
FHLC icon
10119
CALL
Fidelity MSCI Health Care Index ETF
FHLC
$3.47B
$389K ﹤0.01%
+6,100
New +$376K
GMAB icon
10120
Genmab
GMAB
$20.4B
$389K ﹤0.01%
9,526
-55,596
-85% -$2.15M
LTPZ icon
10121
CALL
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$811M
$389K ﹤0.01%
4,500
-7,200
-62% -$599K
ASIX icon
10122
PUT
AdvanSix
ASIX
$445M
$388K ﹤0.01%
13,000
+3,700
+40% +$111K
AVNT icon
10123
PUT
Avient
AVNT
$4.1B
$388K ﹤0.01%
+7,900
New +$400K
DFH icon
10124
PUT
Dream Finders Homes
DFH
$1.34B
$388K ﹤0.01%
+15,900
New +$411K
NGNE icon
10125
Neurogene
NGNE
$732M
$388K ﹤0.01%
2,101
+1,180
+128% +$261K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.